Lung Transplant for International Patients in India

Lung transplantation can be life-extending for carefully selected patients with advanced irreversible lung disease when medical, interventional and rehabilitative treatments can no longer provide an acceptable prognosis or quality of life. It is a highly specialized pathway rather than a surgery that can simply be scheduled on a chosen date.

The transplanted lung is continuously exposed to the external environment, making infection, rejection and chronic allograft dysfunction particularly important. Successful treatment therefore depends as much on lifelong surveillance, medication adherence and rehabilitation as on the operation itself.

A recommendation to consider a lung transplant is one of the hardest a family can hear. The questions are not only whether the operation can be done, but whether it is the right treatment, whether lungs will actually become available, how long you could be waiting, and whether lifelong medicines and monitoring can be maintained once you are home. This guide is written to help you understand which situation you may be in, ask any programme the questions that matter, and organise the whole journey, not only the operation. It does not promise outcomes; every patient is different. Use it alongside your own reports and your own doctors' advice.

When Lung Transplant Is Considered for International Patients in India

Referral is considered when advanced lung disease is progressing despite maximal disease-specific therapy and the expected risk of death without transplantation becomes substantial. Many people live for years with serious lung disease on inhalers, oxygen, rehabilitation and disease-specific medicines. Only a minority progress to the stage where these are no longer enough, and it is these patients who are assessed for transplant.

Major Disease Groups

• Interstitial lung disease, including idiopathic pulmonary fibrosis.
• COPD and severe emphysema.
• Cystic fibrosis and non-CF bronchiectasis.
• Pulmonary arterial hypertension.
• Selected occupational, connective-tissue and rare lung diseases.
• Selected retransplantation for irreversible graft failure.

Referral Is Different from Listing

Referral should occur early enough to optimize nutrition, rehabilitation, infection control and comorbidities. Listing occurs only after the full transplant evaluation confirms acceptable risk and expected benefit.

Disease-Specific Timing

IPF can deteriorate unpredictably and often warrants early referral. COPD may progress more slowly, so quality of life, exacerbations, hypercapnia and prognostic indices matter. Bronchiectasis/CF requires detailed infection and microbiology assessment.

Pulmonary Hypertension

Patients with severe pulmonary arterial hypertension may require transplantation when targeted therapy fails. Right-heart failure and hemodynamic deterioration can accelerate urgency.

Why Do International Patients Consider India for Lung Transplant?

Patients look at India for practical reasons, but lung transplantation differs from other procedures, and the reasons need to be balanced against the legal and waiting-list realities explained in this guide:

• Cost. Private transplant episodes in India are commonly a fraction of private prices in the USA, UK and Australia, though a foreign family's full budget is wider than the headline package.
• Programme experience. A small number of large hospitals run lung-transplant, ECMO and interventional bronchoscopy programmes, and volume is closely linked to safer outcomes.
• Integrated services. Transplant pulmonology, thoracic surgery, cardiothoracic intensive care, infectious-disease and rehabilitation services can sit within one hospital.
• Access to a transplant pathway. Some patients from countries with limited or no lung-transplant services consider India, though allocation to foreign recipients is subject to special provisions as explained above.
• Specialist review before travel. Records can be reviewed remotely, so the team can say whether transplant assessment is reasonable, and whether you are stable enough to travel, before a family commits.
• Language. English is widely used in Indian hospitals, and interpreters can usually be arranged.

India is a sensible option only when the patient is clinically suitable and stable enough to travel, the legal and allocation pathway is clearly explained in writing, the family can finance an uncertain wait, and a reliable follow-up plan exists at home. It is not a good option for a patient who needs very high oxygen flows or is deteriorating and should stay with the team who already knows them, or for anyone offered a guaranteed donor lung.

How Does India Compare with Other Medical Travel Destinations?

Patients sometimes compare India with Singapore, Turkey or the Gulf. For lung transplant, the honest comparison is about legal access and the whole pathway, not the price list:

What Causes the Lung Disease That Leads to Transplant?

Advanced lung failure is not a single disease. The conditions below can each lead to end-stage lung disease, and for some patients no cause is found:

What Are the Symptoms That Lead to Evaluation?

These symptoms are common to many conditions, but in a person with known advanced lung disease they should prompt specialist review rather than waiting. Early referral to a transplant programme gives more options than a late referral during a crisis.

What Makes a Suitable Candidate?

• Advanced irreversible lung disease with meaningful expected survival benefit.
• Adequate rehabilitation potential.
• Acceptable function of other major organs or a feasible combined-organ strategy.
• No uncontrolled infection or active untreated cancer.
• Ability to adhere to complex lifelong treatment.
• Reliable caregiver and follow-up system.

Factors That Increase Risk

• Advanced age/frailty.
• Severe obesity or marked undernutrition.
• Significant coronary/peripheral vascular disease.
• Irreversible kidney/liver dysfunction.
• Poorly controlled diabetes.
• Severe osteoporosis.
• Previous thoracic surgery/pleurodesis.
• Colonization with difficult multidrug-resistant organisms.

These are not a checklist of automatic exclusions. Many can be improved, such as weight, nutrition, blood sugar and fitness, and the team decides how they combine in your case.

Infection

Active uncontrolled infection is generally incompatible with transplantation. In bronchiectasis/CF, chronic airway organisms require organism-specific assessment rather than automatic exclusion.

Malignancy

Active malignancy usually precludes transplant. Previous cancer requires individualized assessment of recurrence risk and cancer-free interval.

Substance Use and Adherence

Active smoking/vaping, harmful substance use or inability to follow treatment can prevent listing. Programmes require demonstrated abstinence and adherence according to policy.

Lung Assessment

• Pulmonary function tests including spirometry and DLCO.
• High-resolution CT chest.
• Six-minute walk testing and oxygen requirement.
• Arterial blood gases where indicated.
• Disease-specific microbiology and sputum cultures.
• Bronchoscopy in selected patients.

Cardiac Assessment

• ECG and echocardiography.
• Right-heart catheterization for pulmonary hypertension/hemodynamic assessment.
• Coronary angiography or CT coronary assessment according to age/risk.
• Assessment of right- and left-heart function.

Other-Organ and General Assessment

• Kidney and liver function.
• Bone density.
• Nutrition and body composition.
• Dental review.
• Age-appropriate cancer screening.
• Gastroesophageal reflux/swallow assessment when relevant.
• Functional/frailty evaluation.

Infectious-Disease Screening

Testing includes tuberculosis and viral infections such as CMV, EBV, hepatitis and HIV according to protocol, plus disease-specific bacterial, fungal and mycobacterial cultures.

Immunologic Testing

Blood group and anti-HLA antibody assessment help identify sensitization and donor compatibility risk.

Psychosocial Evaluation

The team assesses medication adherence, caregiver support, mental health, financial capacity and ability to remain close to the transplant centre during intensive early follow-up. For an international patient, continuity of care in the home country is especially important.

The Evaluation Pathway - At a Glance

Each step can change the plan, and the decision to list is revisited while you wait. A programme that explains this sequence for your case is likely to plan carefully.

Treatment Options - At a Glance

Transplant is one option among several, and the right choice depends on the cause of the lung disease, its severity, your other organs and your wishes. The table summarises how the main pathways compare, and your own team will tailor it:

Is Treatment in India Right for You? A Short Checklist

This checklist is not a decision, but it helps you see whether you are likely to be a good candidate for transplant assessment in India. Ask yourself:

Preparing yourself before treatment (prehab)

Prehab is not about perfection. Staying as well as possible while waiting can keep you eligible, and your team will tell you which activity limits apply, particularly if you need oxygen.

Single-Lung Transplant

One donor lung replaces one native lung. It can be appropriate for selected pulmonary fibrosis or COPD patients and can use the donor resource efficiently.

Bilateral Sequential Lung Transplant for International Patients in India

Both lungs are replaced, usually sequentially during the same operation. Bilateral transplant is commonly favored for bronchiectasis/CF because leaving an infected native lung could contaminate the graft.

Disease and Age Influence the Choice

Heart-Lung Transplant

This is uncommon and reserved for selected patients with irreversible combined heart and lung disease where isolated lung transplantation would not be adequate.

Size Matching

Donor-recipient chest and lung size matching is important. Extreme size mismatch can impair graft function and limits donor options.

A Lung Cannot Be Supplied by a Living Relative in Routine Practice

Standard adult lung transplantation uses deceased-donor lungs. Living-donor lobar transplantation exists only in very specialized circumstances internationally and is not the routine medical-travel pathway.

Registration in India

The patient must be evaluated by an authorized lung-transplant programme and entered into the applicable deceased-donor allocation system according to current Indian regulations.

Foreign-National Considerations

Foreign recipients are subject to special deceased-donor allocation provisions in India. The transplant hospital should explain the current NOTTO/SOTTO/ROTTO rules and realistic priority before the patient relocates.

Why Waiting Time Is Unpredictable

• Donor availability.
• Blood group.
• Body/chest size.
• Clinical urgency and allocation rules.
• Sensitization/compatibility.
• Donor-lung quality.
• Geographic retrieval logistics.
• Foreign-recipient allocation position.

A Donor Offer Can Be Declined

The transplant team may reject a donor because of poor oxygenation, infection, injury, size mismatch or other concerns. A donor call can therefore end without transplantation.

Questions that separate honest from misleading offers

Optimization While Waiting

• Pulmonary rehabilitation.
• Nutrition optimization.
• Vaccination.
• Oxygen therapy.
• Disease-specific medicines.
• Treatment of infection.
• Reflux/aspiration management where relevant.
• Psychological and caregiver preparation.

Oxygen and Noninvasive Support

Many candidates require progressively higher oxygen. High-flow nasal oxygen or noninvasive ventilation can support selected patients.

Mechanical Ventilation

Invasive ventilation increases risk and deconditioning but does not automatically eliminate transplantation in carefully selected patients.

ECMO as Bridge to Transplant

VV-ECMO can support gas exchange in severe respiratory failure. Awake/ambulatory ECMO strategies at experienced centres can preserve conditioning, but bleeding, infection, thrombosis and neurological risks are substantial.

Pulmonary Hypertension Bridge

Patients with severe right-heart failure may need intensive pulmonary vasodilators, inotropes and sometimes VA-ECMO or other specialized support.

Delisting or Temporary Inactivation

Sepsis, major bleeding, new malignancy, severe irreversible organ failure or profound deconditioning can temporarily or permanently change eligibility.

Bridge options compared

Donor Evaluation

• Cause of death and smoking/medical history.
• Chest X-ray/CT where available.
• Bronchoscopy and airway secretions.
• Arterial oxygenation.
• Ventilator parameters.
• Infection testing and cultures.
• Direct surgical inspection at retrieval.

Extended-Criteria Donors

Experienced programmes may safely use selected donors outside older ideal criteria, increasing transplant opportunities. Risk is assessed individually.

Ex Vivo Lung Perfusion (EVLP)
(Lung Transplant for International Patients in India)

EVLP allows selected donor lungs to be perfused and assessed outside the body and may permit reconditioning of some marginal organs. Availability varies by centre and is not required for every transplant.

Transport and Ischemic Time

Retrieval and recipient surgery are tightly coordinated to minimize cold ischemic time. Long-distance retrieval may involve dedicated air/road transport and green-corridor coordination.

Final Cross-Check

Even after the recipient is prepared, transplantation can be cancelled if the retrieval surgeon finds unacceptable donor-lung quality.

Anesthesia and Monitoring

The recipient undergoes general anesthesia, invasive arterial/central monitoring and often transesophageal echocardiography.

Surgical Access

Incisions vary: anterolateral thoracotomy, bilateral 'clamshell' incision or other approaches depending on single/bilateral transplant and anatomy.

Bilateral Sequential Transplant

• One diseased lung is removed.
• Donor bronchus is connected.
• Pulmonary artery is anastomosed.
• Donor atrial cuff/pulmonary veins are connected.
• The graft is reperfused.
• The sequence is repeated on the other side.

Cardiopulmonary Support

Some patients can be transplanted without extracorporeal support; others require ECMO or cardiopulmonary bypass because of pulmonary hypertension, hemodynamic instability or surgical complexity.

Bronchial Anastomosis

The donor bronchial circulation is not directly reconnected, so early airway healing depends on collateral blood supply. This contributes to unique airway complications.

Previous Pleurodesis or Chest Surgery

Dense adhesions can increase bleeding and operative complexity, particularly in cystic fibrosis, prior pneumothorax or previous thoracic surgery.

Surgery day, step by step

A bilateral operation typically takes several hours, and families should expect long waits for news. The team will tell the family how to be contacted.

Immediate ICU Priorities

• Ventilation and oxygenation.
• Hemodynamic support.
• Fluid balance.
• Early graft imaging and bronchoscopy.
• Bleeding/chest drains.
• Kidney function.
• Infection prevention.
• Early immunosuppression.

Primary Graft Dysfunction (PGD)

PGD is acute lung injury occurring in the first 72 hours after transplant and ranges from mild infiltrates to severe hypoxemia. Severe PGD is a major cause of early morbidity and mortality.

Treatment of Severe PGD

Management includes lung-protective ventilation, careful fluid strategy, pulmonary vasodilators and VV-ECMO in severe cases.

Extubation

Early extubation is desirable when stable, but preoperative deconditioning, PGD, airway issues or neuromuscular weakness may prolong ventilation.

Early Bronchoscopy

Bronchoscopy evaluates airway anastomoses, secretions and infection and may be repeated during the early postoperative period.

Rehabilitation Starts in ICU

Sitting, standing, walking and respiratory muscle training begin as early as safely possible because pre-transplant deconditioning can be profound.

Acute Cellular Rejection

Immune cells attack the transplanted lung. It may be asymptomatic or cause dyspnea, cough, fever, hypoxemia or decline in spirometry.

Antibody-Mediated Rejection

Donor-specific antibodies can contribute to graft injury. Diagnosis integrates clinical dysfunction, antibody testing, pathology and other findings.

Surveillance Bronchoscopy and Biopsy

Many programmes use scheduled transbronchial biopsies during the first year, although protocols vary. Bronchoscopy also helps assess infection and airway healing.

Chronic Lung Allograft Dysfunction (CLAD)
(Lung Transplant for International Patients in India)

CLAD is persistent chronic loss of graft function and is a major limitation to long-term survival.

BOS and RAS

Reducing CLAD Risk

Strict adherence, infection control, rejection treatment, reflux/aspiration management and regular spirometry are important, although CLAD can still develop despite excellent care.

Typical Immunosuppression

Most recipients receive a calcineurin inhibitor such as tacrolimus, an antiproliferative agent such as mycophenolate, and corticosteroids, with induction therapy in many programmes.

Drug-Level Monitoring

Tacrolimus/cyclosporine levels require frequent monitoring. Diarrhea, interacting antibiotics/antifungals and herbal medicines can cause dangerous changes.

Infection Risk Is Particularly Important

The lung graft is directly exposed to inhaled organisms. Bacterial pneumonia, CMV, fungal infections and opportunistic infections require active prevention and rapid treatment.

CMV

Donor/recipient CMV serostatus influences risk and prophylaxis duration. CMV can directly injure the graft and is associated with later complications.

Fungal Infection

Aspergillus and other fungi are important in lung recipients, especially with airway ischemia, colonization or intense immunosuppression.

Vaccination and Prevention

Vaccination is optimized before transplant. After transplant, schedules use appropriate non-live vaccines according to transplant guidance.

Food and Environmental Precautions

Safe food handling, clean water, hand hygiene and avoidance of high-risk exposures such as construction dust, mold, gardening soil and sick contacts are especially important in the early months, because the new lungs breathe in the environment directly.

Common side effects of transplant medicines, and what helps

Airway Anastomotic Complications

• Ischemia/necrosis.
• Dehiscence.
• Stenosis.
• Granulation tissue.
• Bronchomalacia.
• Airway infection.

Management of Airway Problems

Bronchoscopic balloon dilation, debridement, laser/cryotherapy or temporary stenting may be required. Severe dehiscence can be life-threatening.

Pleural Complications

Persistent air leak, pneumothorax, hemothorax and pleural infection can prolong hospitalization.

Kidney Injury

Hemodynamic instability and calcineurin-inhibitor toxicity can cause acute or chronic kidney dysfunction.

Neurological and Thrombotic Events

Stroke, delirium, neuropathy, DVT and pulmonary/vascular thrombosis are recognized risks.

Diabetes, Hypertension and Bone Disease

Steroids and calcineurin inhibitors can worsen glucose, blood pressure, lipids and bone density. These require lifelong management.

Cancer Risk

Long-term immunosuppression increases skin cancer and post-transplant lymphoproliferative and other malignancy risks.

What Could Go Wrong After a Lung Transplant for International Patients in India?

No honest programme can quote one risk figure for every patient, because risk depends on how ill you are before surgery, the disease, the donor lungs, your other organs and your response to immunosuppression. Ask the team for its own figures for patients like you.

When to Contact the Transplant Team Urgently

• Fall in home FEV1.
• Fever, new cough or sputum.
• New breathlessness or lower oxygen saturation.
• Persistent vomiting/diarrhea.
• Reduced urine output.
• New chest pain.
• Missed immunosuppression.
• Exposure to a significant infection.

Warning signs can be subtle, and a small fall in lung function can be the first sign of trouble. Share the table below with your companion and keep the transplant team's emergency number on your phone.

What You Can Do to Reduce Your Risk

Why Rehabilitation Is Essential

Many candidates enter transplant with months or years of inactivity, muscle loss and steroid exposure. The new lungs do not automatically restore strength.

Typical Recovery Timeline

The table above gives the general focus, and the table below shows what you and your companion may experience and can do at each stage. Primary graft dysfunction, rejection, infection and the severity of your illness before transplant can change the timetable.

Nutrition

Protein/calorie support may be needed early. Later, weight control, diabetes prevention, food hygiene and cardiovascular risk reduction become priorities.

Home Spirometry

Many programmes ask patients to measure lung function at home. A sustained fall in FEV1 can be an early sign of infection, rejection or CLAD.

Return to Work and Activity

Many successful recipients regain substantial independence. Timing depends on strength, complications, infection exposure and job demands.

When Can a Patient Fly?

There is no universal fixed day. The transplant team considers oxygenation, graft function, bronchoscopy findings, wound healing, infection/rejection status, mobility, DVT risk and medication stability.

Flight Preparation

• Carry immunosuppressants and extra supply in hand luggage.
• Keep medication timing correct across time zones.
• Carry discharge summary and emergency transplant contacts.
• Use infection precautions advised by the team.
• Request wheelchair assistance if needed.
• Maintain hydration and mobility as permitted.
• Confirm destination transplant care before departure.

Oxygen After Transplant

Many successful recipients no longer need supplemental oxygen, but patients with early graft dysfunction or complications may still require it and need airline-specific arrangements.

Emergency Plan at Home

The patient should know which hospital can perform urgent spirometry, CT, bronchoscopy, drug levels and treatment of severe infection/rejection.

Medication Supply

Never return home without confirming reliable access to tacrolimus/cyclosporine, mycophenolate and all prophylactic medicines.

How Long to Stay Near the Transplant Hospital

The hospital stay is often roughly 3-5 weeks when uncomplicated, followed by weeks of close outpatient monitoring. Families should plan for a long stay after the operation itself, plus the waiting period before it, and keep return dates flexible until the team confirms that it is safe to fly.

Practical Questions Patients Ask After the Operation

When can I leave the ICU and the hospital? Often after several days in the ICU and roughly 3-5 weeks in hospital when all goes well, but graft dysfunction, rejection, infection or kidney problems can extend this. Will I still need oxygen? Many recipients no longer need supplemental oxygen, but some need it for a time after early complications. When can I start walking and exercising? Sitting and standing begin in the ICU, and walking soon after. Structured pulmonary rehabilitation continues for months.

Can I eat normally? Usually yes, from the first days. Food hygiene is very important, and your dietitian will advise about raw foods, grapefruit and salt. Can I lift or drive? Lifting is limited while the chest incision heals, often for about six to eight weeks. Driving depends on healing, strength and local rules. Will I need frequent bronchoscopies and biopsies? They are frequent in the first year and become less frequent if the graft is stable, although protocols vary. Can I return to work? Many patients return gradually after recovery, with timing individualised to the job and your health.

Can I have follow-up at home? Yes, if a home pulmonologist or transplant centre agrees to share care and your Indian team is available for remote advice. Do I need to avoid crowds and dust? In the early months, yes, as advised by your team. Masks, hand hygiene and avoiding construction dust and mold reduce infection risk. Can I travel again after transplant? Often yes, after you are stable and have a reliable medicine supply and care plan at your destination.

Travel Practicalities After Lung Transplant for International Patients in India

Routine Monitoring

• Symptoms and oxygen saturation.
• Home and laboratory spirometry.
• Tacrolimus/cyclosporine trough levels.
• Kidney/liver function and blood counts.
• CMV and other infection monitoring.
• Bronchoscopy/biopsy according to centre protocol.
• Imaging.
• Metabolic and cancer surveillance.

Long-Term Lifestyle

Regular exercise, healthy weight, sun protection, food safety, vaccination, dental care and avoidance of smoking/vaping are essential.

Retransplantation

Selected patients with irreversible graft failure may be evaluated for retransplantation, but risk is higher and donor allocation must be considered carefully.

Emotional Wellbeing and Realistic Expectations

Waiting for donor lungs, the sudden call and a long recovery in a foreign country are emotionally exhausting for patients and families. Anxiety, low mood, guilt about the donor family and fear of rejection are common, and they respond to support. Tell your team if low mood, anxiety or poor sleep continues, because treatment helps. Counselling, a transplant support group and a sense of purpose through rehabilitation all matter, and your companion needs support too.

Living after lung transplant at a glance

Special Situations

Questions to Ask

• How many lung transplants does the programme perform each year?
• What proportion are bilateral vs single?
• What are early survival and major complication rates?
• How often is ECMO used before/during/after transplant?
• Is EVLP available or used through a partner programme?
• How are foreign recipients registered and prioritized?
• How are airway complications managed?
• What is the bronchoscopy/biopsy surveillance schedule?
• How will follow-up be coordinated after I return home?

Four more questions to ask

• Will the surgeon and transplant pulmonologist who review my records be the ones who manage me, and who covers when they are away?
• Will my case be discussed by the transplant selection committee before I am listed, and can I receive its decision in writing?
• Can I speak with a previous international transplant patient, or see the cardiothoracic ICU and ward?
• Who will manage my immunosuppression and send reports to my home doctor after I return?

Essential Programme Capabilities

• Transplant pulmonology and thoracic transplant surgery.
• 24/7 cardiothoracic ICU.
• ECMO team.
• Interventional bronchoscopy.
• Transplant infectious disease and microbiology.
• HLA/immunology support.
• Pulmonary rehabilitation.
• Radiology/pathology.
• Dedicated transplant coordinators and international-patient services.

What a Good International Patient Service Should Provide

Red Flags

• Guaranteed donor lung or transplant date.
• Commercial donor offer.
• No explanation of foreign-patient allocation.
• No ECMO capability for a high-risk programme.
• No bronchoscopy/airway-intervention service.
• No clear post-discharge monitoring plan.
• Price quotation without ICU/ECMO/complication exclusions.

What to Expect: A Realistic Picture of Outcomes

No guide can tell you your own outlook, which only your transplant team can estimate from your disease, your age and fitness, your other organs, antibodies, donor factors and adherence. In general terms, a lung transplant can improve breathing, exercise capacity and quality of life, but it exchanges one set of problems for another, and long-term survival is limited mainly by chronic graft dysfunction, infection and the effects of immunosuppression. Published figures from large US centres put survival at roughly nine in ten recipients at one year and around 50-60% at five years, with some recipients living beyond ten years, and results vary by disease, centre and patient:

Use these as orientation only. Ask your own team for its programme-specific results for patients like you, and be wary of any centre that quotes an unusually high success rate without stating how patients were selected.

Indicative Cost Components

Broad India Planning Range

For an international patient, a relatively uncomplicated lung-transplant episode may broadly fall around US$35,000-60,000+, depending on centre and whether single or bilateral transplantation is required. ECMO, prolonged ventilation, dialysis, infection, airway intervention or extended ICU care can raise the total substantially.

Costs Before and After Surgery

The advertised transplant package is only one part of total expenditure. A long waiting period, high-flow oxygen, hospitalization, caregiver accommodation and months of early follow-up can be significant.

Lifelong Cost

Immunosuppressants, prophylactic medicines, laboratory testing, spirometry, CT/bronchoscopy and travel for transplant review continue after the initial episode.

Why a One-Price Package Is Misleading

Lung-transplant cost varies dramatically with how ill the patient is, whether the transplant is single or bilateral, whether ECMO or bypass is needed, the length of ICU stay, airway or kidney complications, infection and rejection. Two patients with the same diagnosis can have very different totals, so be wary of any single package price that appears to cover everything.

Broad International Cost Comparison

*Broad planning estimates only. Donor access and allocation rules make international transplant-price comparisons fundamentally different from elective surgery comparisons. Savings are calculated against the India midpoint and rounded, and the Canada and Singapore rows are indicative additions. Many countries restrict or prioritise donor lungs for their own residents, so a lower price abroad does not mean a foreign patient can actually be listed there, and the price comparison matters only if a legal pathway to donor lungs exists.

What the Quote Should State

• Single or bilateral transplant assumption.
• Expected ICU and ward days.
• ECMO/bypass inclusion or exclusion.
• Donor retrieval/transport.
• Bronchoscopy and biopsy coverage.
• Blood products.
• Dialysis.
• Reoperation.
• Infection treatment.
• Immunosuppression during admission.
• Post-discharge clinic/testing.
• Accommodation and oxygen during waiting.

Do Not Choose a Programme on Price Alone

Volume, outcomes, donor utilization, ECMO capability, infection expertise, airway intervention and long-term follow-up are more important than a small difference in package price.

Budgeting for the Whole Pathway, Not Just the Operation

The hospital quote is only part of the budget. A realistic plan also includes:

• Return flights for you and a caregiver, with flexible dates, wheelchair assistance and, if needed, medical oxygen or air ambulance transport.
• Accommodation and meals near the hospital for the waiting period, if required, and for several weeks to months after transplant.
• Home oxygen equipment and supplies while waiting, and repeated clinic visits, tests, drug levels and bronchoscopies while listed and after transplant.
• Lifelong immunosuppressants and other medicines, with a plan for supply at home.
• Emergency admission, ventilation or ECMO support if you deteriorate while waiting.
• Medical visa fees and travel insurance that covers complications.
• Follow-up tests, spirometry and consultations at home, and possible future care for rejection or chronic graft dysfunction.
• A contingency for a longer wait, extra ICU days, infection or a cancelled donor call.

Quotation Comparison Table

Use this table to compare written quotations from two hospitals on the same terms:

What Should the Quotation Say About Complications?

• Who pays if a complication such as graft dysfunction, rejection, infection, airway problems, bleeding or kidney failure occurs during the same admission?
• What is charged if the stay is longer than planned, ICU care is extended or a second operation is needed?
• Whether ECMO, dialysis, bronchoscopic interventions, return to theatre and readmission are covered, and for how long after surgery.
• What follow-up visits, spirometry, drug levels and bronchoscopies are included before you leave India.
• Whether remote follow-up with the team after you return home is free or charged.

Remote Review Before Travel

• Send HRCT chest images and reports.
• Complete PFTs and six-minute walk.
• Oxygen requirement and ABG if available.
• Echo/right-heart catheterization.
• Microbiology/sputum cultures.
• Hospitalization/exacerbation history.
• Current medicines and oxygen/NIV settings.
• Prior chest operations/pleurodesis.
• Passport/nationality details for allocation/logistical review.

A good review says whether transplantation is likely to be the right option, whether another treatment could help first, what the foreign-national pathway looks like, whether you are stable enough to travel and what must be clarified before you relocate.

Travel While Severely Hypoxemic

Commercial-flight oxygen availability may be insufficient for very high-flow requirements. Some candidates are too unstable for routine air travel and require specialized medical transport.

Caregiver

A dedicated caregiver is strongly recommended throughout evaluation, waiting and early recovery.

Accommodation

After discharge, clean accommodation close to the hospital is important. Avoid construction dust, mold and high infection exposures.

Flexible Visa and Travel Plan

The waiting period cannot be scheduled. Visa validity, accommodation and finances should allow uncertainty, subject to current immigration and transplant rules.

International Patient Pathway

Why the Post-Discharge Stay Matters

The first weeks have high risk of infection, acute rejection, airway complications and drug-level instability. Leaving India too early without equivalent transplant care can be unsafe.

If the Patient Cannot Be Listed

The team should explain why and discuss alternatives such as optimized disease-specific therapy, palliative/supportive care or another transplant-centre opinion where appropriate.

Medical Visa and Attendant

Confirm current Indian medical/e-Medical visa eligibility and attendant rules for your nationality. Hospitals generally provide treatment/invitation letters after medical review, and requirements can change. Most patients apply for an e-Medical Visa, and a caregiver can apply for an e-Medical Attendant Visa. Because the waiting period is uncertain, ask the hospital and the Indian mission how extensions are handled before you travel, and check fees, validity and eligible nationalities on the official Indian e-Visa website.

Documents to Carry Home

• Operative report and discharge summary.
• Immunosuppression regimen with target drug levels.
• Bronchoscopy, biopsy and rejection reports.
• Baseline spirometry, CT and oxygen findings.
• Donor/recipient CMV and serology information appropriate for follow-up.
• Infection-prophylaxis plan.
• Vaccination guidance.
• Emergency contact and scheduled review dates.

Your information pack: why each item matters

Arranging Your Follow-Up at Home Before You Leave

Identify a pulmonologist, ideally one with transplant experience, a laboratory able to measure tacrolimus or cyclosporine levels, a spirometry service, a pharmacy that can reliably supply your medicines and, if possible, a transplant centre willing to share care. Send them your records before you travel, and agree how your Indian team will receive results and advise on dose changes.

Language, Consent and Communication

• Ask for the consent form and discharge instructions in a language you understand.
• Ask for an interpreter if your English is limited; do not rely on guesses for risks or medicines.
• Make sure the consent explains the transplant, the chance of rejection, infection, airway problems, kidney injury and graft failure, the need for lifelong medicines and what happens if the donor lung is unsuitable.
• If the patient is a minor, make sure the parent or guardian's consent and the child's own understanding are both addressed.
• Agree who will receive updates, and how, if you cannot answer on the day, including during an urgent donor call.
• Save the hospital, transplant coordinator and surgeon contact numbers before you travel, and keep your own copies of everything you sign.

Records Checklist for a Second Opinion

• HRCT chest images and reports.
• Pulmonary function tests including DLCO, and six-minute walk.
• Oxygen requirement and arterial blood gases.
• Echocardiogram and right-heart catheterisation if available.
• Sputum and microbiology reports.
• Hospital admission history and current treatment.
• Kidney and liver tests, blood count and blood group.
• Passport and nationality information.

Frequently Asked Questions About Lung Transplant for International Patients in India

Lung Transplant Checklist for International Patients in India

Swipe to Read

Final Perspective for International Patients

Transplant care works best when the need is certain, alternatives have been considered, the pathway to donor lungs is explained honestly, and the whole journey, from waiting to lifelong follow-up, is budgeted and arranged in advance. For an international patient considering India, the review of your records, the honesty about what a foreign recipient can realistically expect, the clarity about waiting costs and complications, and the arrangement of follow-up at home are as important as the operation itself.

Educational guide only. Lung-transplant candidacy, donor allocation, medical-visa requirements and travel decisions require individualized assessment by an authorized transplant programme and must follow current Indian regulations.

Important Medical Note. This guide is educational and does not replace individualized assessment by an authorized transplant programme. Lung-transplant candidacy, donor allocation, medical-visa requirements and travel decisions must follow current Indian regulations. Costs, timelines and rules vary by patient and hospital, and the figures here are planning ranges to be confirmed in writing by the treating team.